A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: better (428), greater (578), bigger (32), higher (354), finer (2), better-quality (19), excellent (106)

Procedure for adult circumference measurements

Description
NIHR Southampton Biomedical Research Centre The NIHR Southampton Biomedical Research Centre (BRC) has a tight quality a
Url
/Media/Southampton-Clinical-Research/Procedures/BRCProcedures/Procedure-for-adult-circumference-measurements.pdf

Removal of skin-tunnelled central venous access device (CVAD) - Cancer care unit - patient information

Description
This factsheet explains why your skin-tunnelled central venous access device (CVAD) needs to be removed, what the procedure involves and
Url
/Media/UHS-website-2019/Patientinformation/Cancercare/Removal-of-skin-tunnelled-central-venous-access-device-CVAD-Cancer-care-unit-3874-PIL.pdf

InP IVE-Epirubicin-Etoposide-Ifosfamide Ver1.1

Description
Chemotherapy Protocol LYMPHOMA EPIRUBICIN-ETOPOSIDE-IFOSFAMIDE (IVE) Inpatient Regimen Regimen • Lymphoma – InP-IVE-Epiru
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/InP-IVE-Epirubicin-Etoposide-Ifosfamide.pdf

InP RIVE-Epirubicin-Etoposide-Ifosfamide-Rituximab Ver1.1

Description
Chemotherapy Protocol LYMPHOMA EPIRUBICIN-ETOPOSIDE-IFOSFAMIDE-RITUXIMAB (RIVE) Inpatient Regimen Regimen Lymphoma – InP-
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/InP-RIVE-Epirubicin-Etoposide-Ifosfamide-Rituximab.pdf

MyelomaVTDBortezomib(SC)DexamethasoneThalidomideVer1

Description
Chemotherapy Protocol MULTIPLE MYELOMA VTD (SC-28)-BORTEZOMIB (SC)-DEXAMETHASONE-THALIDOMIDE (28 day) Regimen Multiple Myeloma – VTD (28)-Bortezomib (SC)-Dexa
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/MyelomaVTDBortezomibSCDexamethasoneThalidomideVer1.pdf

MyelomaVTDBortezomib(IV)DexamethasoneThalidomideVer1

Description
Chemotherapy Protocol MULTIPLE MYELOMA VTD (IV-28)-BORTEZOMIB (IV)-DEXAMETHASONE-THALIDOMIDE (28 day) Regimen Multiple Myeloma – VTD (IV-28)-Bortezomib (IV)-D
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/MyelomaVTDBortezomibIVDexamethasoneThalidomideVer1.pdf

UHSNFT Ultrasound Referral guidelines for GPs V6- new neck referral included

Description
UNIVERSITY HOPSITAL SOUTHAMPTON GUIDELINES FOR GP ULTRASOUND REFERRALS IN ADULTS Introduction Ultrasound is often used as a first line investigation
Url
/Media/UHS-website-2019/Docs/Services/Radiology/UHSNFT-Ultrasound-Referral-guidelines-for-GPs-V6-new-neck-referral-included.pdf

RPMitCEBO-Bleomycin-Cyclophosphamide-Etoposide-Mitoxantrone-Prednisolone-Rituximab-Vincristine Ver 1.4

Description
Chemotherapy Protocol LYMPHOMA BLEOMYCIN-CYCLOPHOSPHAMIDE-ETOPOSIDE-MITOXANTRONE-PREDNISOLONERITUXIMAB-VINCRIS
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/RPMitCEBO-Bleomycin-Cyclophosphamide-Etoposide-Mitoxantrone-Prednisolone-Rituximab-Vincristine-Ver-1.4.pdf

DH IVIg approved indications full guidance July 2011

Description
DH INFORMATION READER BOX Policy HR / Workforce Management Planning / Clinical Performance Document Purpose Gateway Reference Title Author Publication Date Target Audienc
Url
/Media/SUHTExtranet/TrustMedicinesFormulary/Forms/DH-IVIg-approved-indications-Full-Guidance-July-2011.pdf

Papers Trust Board 27 May 2021

Description
Date Time Location Chair Agenda Trust Board – Open Session 27/05/2021 9:00 - 13:00 Microsoft Teams Peter Hollins 1
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2021-Trust-document/TB-papers/Papers-Trust-Board-27-May-2021.pdf
1 to 10 of 12
Previous 1 2 Next